Member Articles
COVID-19: Temporary Importation Measures on Medicines and other Human Health Products
Related Articles inHealthcare & Pharmaceuticals | Government & Public Sector
More Healthcare & Pharmaceuticals | Government & Public Sector Aricles → Latest Firm's PressMorgan & Morgan
In order to allow the importation of medicines and other products for human health
The aforementionedPDFdocuments
Theaforementioned documentationis the responsibility of the pharmaceutical manager and / or the representative of theestablishment andwill be subject toreviewbythe DNFYD.
Theaforementioned resolutiontakes effect on April 23, 2020 and willremain ineffectfor the duration of the national state of emergency.
|
Related Articles in
Healthcare & Pharmaceuticals | Government & Public Sector
- How will Brexit impact UK IP Rights? Introduction
January, 2021 - COVID-19 Alert: Israel Bans the Entry of Foreigners
January, 2021 - Buchalter COVID-19 Client Alert: New Treasury PPP Rules Clarify Recent Changes to PPP Program, Extend Time to Obtain a PPP Loan to March 31, 2021
January, 2021 - The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?
January, 2021
More Healthcare & Pharmaceuticals | Government & Public Sector Aricles →
Latest Firm's Press
Morgan & Morgan
- Morgan & Morgan Advised Farmalisto in an Equity Investment of Various Investors
December, 2020 - Morgan & Morgan Advised Banistmo, S.A. in Connection with the Public Offering of Senior Secured Notes for an Amount of up to US$400 Million Issued Through the ENA Master Trust
December, 2020 - Morgan & Morgan Advised Itaú Corpbanca in Connection with Two Credit Facilities for an Amount of up to US$83,801,622.00 and COP 367,366,730,694.00
December, 2020